Amelia Adams is an experienced professional specializing in research and development within the biotechnology sector. Currently serving as Associate Director at GRAIL, Inc. since July 2018, Amelia leads a team focused on the development of reagents for sequencing assays, overseeing optimization, quality control methods, and technology transfer. Prior experience includes roles at Genentech from August 2013 to June 2018, where Amelia advanced through various engineering positions, including Engineer II and Process Engineering Manager, contributing to drug substance process engineering and manufacturing support. Amelia holds a degree in Bioengineering from Cornell University.